Jump to navigation
It's up to the individual pharmacy.
There is scope for streamlining
Much depends on the covariates used, a study shows.
Explainer: The ambitious scheme has wilted rapidly after being subjected to public scrutiny.
Strokecheck is fending off allegations of disease-mongering, saying its mission is simply to raise stroke awareness...
Is GP fear getting in the way of treatment?
The CHA2-DS2-VASc leads to too much anticoagulation in low-risk patients, they say.
Its early benefit for secondary prevention has been underestimated
Might the drug have been underestimated?
Inside Story: NOACS are hardly novel anymore, but many GPs are still wary about safety.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.